Fisher & Paykel Healthcare share price on watch after guidance upgrade

The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price will be on watch after upgrading its guidance…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price looks set to start the week on a high.

This morning the sleep treatment focused medical device company provided a positive market update and upgraded its guidance for the 12 months ending March 31.

At the time of writing the company's NZ listed shares are up almost 4% in early trade.

What did Fisher & Paykel Healthcare announce?

This morning Fisher & Paykel Healthcare announced an upgrade to both its revenue and earnings guidance following receipt of regulatory clearance for its F&P Vitera mask in the United States.

The Vitera device is the company's new full face mask used in the treatment of obstructive sleep apnoea (OSA).

Previously, the company was expecting to report operating revenue of approximately NZ$1.17 billion and net profit after tax in the range of approximately NZ$245 million to NZ$255 million.

But following this regulatory clearance, and assuming a NZ:US exchange rate of approximately 63 NZ cents, the company now expects full year operating revenue to be approximately NZ$1.19 billion and net profit after tax to be in the range of approximately NZ$255 million to NZ$265 million.

The company's managing director and CEO, Lewis Gradon, appeared very positive on the launch of the Vitera mask in the United States after a strong start in other markets.

He said: "We have had an ongoing strong start to the year in our Hospital product group and our new OSA mask, Vitera, has been well received in Australia, Canada, New Zealand and Europe. Clearance of Vitera for sale in the US this month is sooner than we had previously guided and this has been a meaningful contributor to the increase in our guidance."

At this stage, management advised that there are no changes to the revenue and earnings guidance previously provided for the first half of the 2020 financial year.

Fellow sleep treatment company ResMed Inc. (ASX: RMD) will also be one to watch this month. It is scheduled to release its first quarter update next week.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Oil industry worker climbing up metal construction and smiling.
Energy Shares

ASX 200 energy shares lead the market as US trade deals fuel optimism

ASX energy shares lifted 3.94% as more US trade deals led to improved market sentiment.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »